Pharmaphie SDW: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharmaphie SDW
Largest movements
- Tangible fixed assets +€196,542
up €196,542 (+28.2%), from €696,451 to €892,993
of which Plant, machinery and equipment: +€223,282
- Receivables within one year -€38,992
down €38,992 (-26.4%), from €147,489 to €108,497
of which Trade receivables: -€41,492
- Cash -€33,524
down €33,524 (-64.0%), from €52,414 to €18,889
mainly Investment in fixed assets (net) (-€249,774) and Trade debts (-€61,328)
- Debts after one year +€152,231
up €152,231 (+37.6%), from €404,444 to €556,676
- Trade debts -€61,328
down €61,328 (-40.1%), from €152,978 to €91,651
- Current portion of long-term debt +€22,000
up €22,000 (+50.8%), from €43,333 to €65,333
- Gross operating margin -€47,856
down €47,856 (-19.8%), from €241,399 to €193,543
- Depreciation +€22,291
up €22,291 (+72.0%), from €30,941 to €53,232
- Taxes -€18,203
down €18,203 (-100%), from €18,203 to €0
- Financial charges +€2,698
up €2,698 (+8.4%), from €32,186 to €34,884
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,075,919 | €1,188,176 | +€112,258 | +10.4% |
| Fixed assets | 21/28 | €696,601 | €893,143 | +€196,542 | +28.2% |
| Tangible fixed assets | 22/27 | €696,451 | €892,993 | +€196,542 | +28.2% |
| Land and buildings | 22 | €663,227 | €636,487 | -€26,740 | -4.0% |
| Plant, machinery and equipment | 23 | €33,224 | €256,506 | +€223,282 | +672% |
| Financial fixed assets | 28 | €150 | €150 | = | 0.0% |
| Current assets | 29/58 | €379,318 | €295,033 | -€84,285 | -22.2% |
| Stocks and contracts in progress | 3 | €177,641 | €165,952 | -€11,689 | -6.6% |
| Stocks | 30/36 | €177,641 | €165,952 | -€11,689 | -6.6% |
| Amounts receivable within one year | 40/41 | €147,489 | €108,497 | -€38,992 | -26.4% |
| Trade receivables | 40 | €147,489 | €105,997 | -€41,492 | -28.1% |
| Other amounts receivable | 41 | €0 | €2,500 | +€2,500 | |
| Cash at bank and in hand | 54/58 | €52,414 | €18,889 | -€33,524 | -64.0% |
| Deferred charges and accrued income | 490/1 | €1,774 | €1,695 | -€79 | -4.4% |
| Total equity and liabilities | 10/49 | €1,075,919 | €1,188,176 | +€112,258 | +10.4% |
| Equity | 10/15 | €425,814 | €421,867 | -€3,946 | -0.9% |
| Contributions | 10/11 | €59,670 | €59,670 | = | 0.0% |
| Reserves | 13 | €366,144 | €366,144 | = | 0.0% |
| Non-distributable reserves | 130/1 | €5,967 | €5,967 | = | 0.0% |
| Reserves not available under the articles | 1311 | €5,967 | €5,967 | = | 0.0% |
| Distributable reserves | 133 | €360,177 | €360,177 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | -€3,946 | -€3,946 | |
| Amounts payable | 17/49 | €650,105 | €766,309 | +€116,204 | +17.9% |
| Amounts payable after more than one year | 17 | €404,444 | €556,676 | +€152,231 | +37.6% |
| Financial debts | 170/4 | €404,444 | €556,676 | +€152,231 | +37.6% |
| Amounts payable within one year | 42/48 | €219,763 | €185,925 | -€33,838 | -15.4% |
| Current portion of amounts payable after more than one year | 42 | €43,333 | €65,333 | +€22,000 | +50.8% |
| Trade debts | 44 | €152,978 | €91,651 | -€61,328 | -40.1% |
| Suppliers | 440/4 | €152,978 | €91,651 | -€61,328 | -40.1% |
| Taxes, remuneration and social security | 45 | €23,451 | €28,941 | +€5,490 | +23.4% |
| Taxes | 450/3 | €11,956 | €13,541 | +€1,584 | +13.3% |
| Remuneration and social security | 454/9 | €11,495 | €15,401 | +€3,906 | +34.0% |
| Accrued charges and deferred income | 492/3 | €25,898 | €23,708 | -€2,190 | -8.5% |
| Remuneration, social security and pensions | 62 | €105,491 | €107,524 | +€2,032 | +1.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €30,941 | €53,232 | +€22,291 | +72.0% |
| Other operating charges | 640/8 | €3,491 | €4,094 | +€603 | +17.3% |
| Gross operating margin | 9900 | €241,399 | €193,543 | -€47,856 | -19.8% |
| Operating profit (loss) | 9901 | €101,475 | €28,694 | -€72,782 | -71.7% |
| Financial income | 75/76B | €1,945 | €2,244 | +€299 | +15.4% |
| Recurring financial income | 75 | €1,945 | €2,244 | +€299 | +15.4% |
| Financial charges | 65/66B | €32,186 | €34,884 | +€2,698 | +8.4% |
| Recurring financial charges | 65 | €32,186 | €34,884 | +€2,698 | +8.4% |
| Profit (loss) for the period before taxes | 9903 | €71,235 | -€3,946 | -€75,181 | |
| Income taxes | 67/77 | €18,203 | €0 | -€18,203 | -100% |
| Profit (loss) for the period | 9904 | €53,031 | -€3,946 | -€56,978 | |
| Profit (loss) for the period to be appropriated | 9905 | €53,031 | -€3,946 | -€56,978 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.